Company profile
Thylacine Bio company profile
Thylacine Bio engages in developing a peptide platform for pandemic preparedness. The platform can be rapidly tuned and applied to new and existing pathogens. It targets conserved regions less susceptible to mutation, unlocking efficacy across variants. The resulting antivirals are potent, self-administered, and easily distributed.
Business identity
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0+
- Founded
- 2021-01-01, Year
Headquarters
- Headquarters
- Headland, Alabama, United States
- Postal code
- 33141
- Country code
- US
- Continent
- North America